Skip to main content

Carnexiv FDA Approval History

FDA Approved: Yes (Discontinued) (First approved October 7, 2016)
Brand name: Carnexiv
Generic name: carbamazepine
Dosage form: Injection
Company: Lundbeck Inc.
Treatment for: Seizures

Marketing Status: Discontinued

Carnexiv (carbamazepine) is an intravenous injection formulation of the antiepileptic drug carbamazepine indicated as short-term replacement therapy for oral carbamazepine when oral administration is temporarily not feasible.

Development timeline for Carnexiv

Oct  7, 2016Approval FDA Approves Carnexiv (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types
Apr 22, 2016FDA Accepts Lundbeck Resubmission of New Drug Application for Carnexiv (carbamazepine)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.